Protagenic Therapeutics- Warrants (13/04/2025) Common Stock

Protagenic Therapeutics- Warrants (13/04/2025) (PTIXW) currently reports a common stock of $200 as of December 2025. That compares with $730 in the prior-year period — down 73.1% year over year. Use the charts on this page to explore Protagenic Therapeutics- Warrants (13/04/2025)'s common stock history and peer comparisons.

Protagenic Therapeutics- Warrants (13/04/2025)'s common stock decreased from $730 to $200 — a 73.1% year-over-year decrease (period ending December 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Protagenic Therapeutics- Warrants (13/04/2025) reported $200 in common stock as of December 2025. That compares with $730 in the prior-year period — down 73.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current common stock of $200, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Protagenic Therapeutics- Warrants (13/04/2025), and consider following PTIXW for alerts when major investors trade the stock.

Protagenic Therapeutics- Warrants (13/04/2025) is classified in the Industrials sector. On common stock, it currently shows $200. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Industrials are usually more informative than comparing PTIXW with unrelated industries.